{'fraction_non_alphanumeric': 0.018421052631578946, 'fraction_numerical': 0.005263157894736842, 'mean_word_length': 5.137096774193548, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Using clinically stable disease (NEDA 2) as a proxy for disease impact and employment in MS paints an incomplete picture

Multiple sclerosis (MS) has long been associated with high rates of unemployment.1 While in many countries, patients are entitled to ask for reasonable accommodations,2 the duty to accommodate still operates within the confines of being able to fulfil the job requirements. Fluctuations in disease and pseudo exacerbations can confound meeting these requirements, making permanent and meaningful employment out of reach for many, as most people with MS are not free of all disease activity.3 Obstacles to employment are multifactorial and can be independent of clinically stable disease, a measurement used in the paper by Ameri et al . …